Verdence Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,500
Closed -$2K 263
2018
Q3
$2K Sell
2,500
-5,000
-67% -$85.9K ﹤0.01% 264
2018
Q2
$8K Sell
7,500
-5,000
-40% -$100K ﹤0.01% 293
2018
Q1
$17K Buy
+12,500
New +$261K ﹤0.01% 287

Other funds holding PTEN

Verdence Capital Advisors's PTEN Position: Q2 2019 in Review

Verdence Capital Advisors sold out of Patterson-UTI (PTEN) in Q2 2019, closing a stake of 11,270 shares — an estimated $158K sold.

Verdence Capital Advisors first reported a position in PTEN in Q4 2017 and held it in 6 quarters. The position peaked at $5.3M in Q4 2017. 278 funds tracked by Wall St. Rank hold PTEN as of Q2 2019.

  • Verdence Capital Advisors reported no remaining Patterson-UTI position as of Q2 2019 after selling out during the quarter.
  • Verdence Capital Advisors sold 11,270 Patterson-UTI shares in Q2 2019, an estimated $158K.
  • Verdence Capital Advisors first reported a position in Patterson-UTI in Q4 2017 and held it in 6 quarters.
  • Verdence Capital Advisors's Patterson-UTI position peaked at $5.3M in Q4 2017.
  • 278 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2019.

Based on Verdence Capital Advisors's 13F filing for Q2 2019, filed 2 Mar 2020.